Skip to content

This content is in French.

Efficacy and safety of denosumab and teriparatide compared with oral bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and meta-analysis

17 septembre 2024

Efficacy and safety of denosumab and teriparatide compared with oral bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and meta-analysis
Although bisphosphonates have traditionally been the cornerstone of pharmacological management of bone protection in patients, new evidence suggests that teriparatide and denosumab merit further investigation as potential first-line treatments. The optimal choice between denosumab, teriparatide and oral bisphosphonates for the treatment of postmenopausal osteoporosis remains a subject of debate and controversy within the scientific community.

Sign in to read the rest

Reserved for healthcare professionals, free registration.

Scientific reference

Yang J ; Guo X ; Cui Z ; Guo H ; Dong JN

View the source